Search Results - "Roy, Nand K"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far by Bordoloi, Devivasha, Roy, Nand K, Monisha, Javadi, Padmavathi, Ganesan, Kunnumakkara, Ajaikumar B

    “…Research over the past several years has developed many mono-targeted therapies for the prevention and treatment of cancer, but it still remains one of the…”
    Get more information
    Journal Article
  2. 2

    A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers by Wong, Derek P., Roy, Nand K., Zhang, Keman, Anukanth, Anusha, Asthana, Abhishek, Shirkey-Son, Nicole J., Dunmire, Samantha, Jones, Bryan J., Lahr, Walker S., Webber, Beau R., Moriarity, Branden S., Caimi, Paolo, Parameswaran, Reshmi

    Published in Nature communications (11-01-2022)
    “…B cell-activating factor (BAFF) binds the three receptors BAFF-R, BCMA, and TACI, predominantly expressed on mature B cells. Almost all B cell cancers are…”
    Get full text
    Journal Article
  3. 3

    Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases by Kunnumakkara, Ajaikumar B, Banik, Kishore, Bordoloi, Devivasha, Harsha, Choudhary, Sailo, Bethsebie L, Padmavathi, Ganesan, Roy, Nand K, Gupta, Subash C, Aggarwal, Bharat B

    Published in Frontiers in pharmacology (06-08-2018)
    “…Extensive research during last 2 decades has revealed that most drugs discovered today, although costs billions of dollars for discovery, and yet they are…”
    Get full text
    Journal Article
  4. 4
  5. 5

    NF-κB c-Rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK Cells by Vicioso, Yorleny, Wong, Derek P, Roy, Nand K, Das, Nayanika, Zhang, Keman, Ramakrishnan, Parameswaran, Parameswaran, Reshmi

    Published in Frontiers in immunology (29-04-2021)
    “…Natural Killer (NK) cells are cytotoxic lymphocytes critical to the innate immune system. We found that germline deficiency of NF-κB c-Rel results in a marked…”
    Get full text
    Journal Article
  6. 6

    BAFF receptor antibody for mantle cell lymphoma therapy by Zhang, Keman, Roy, Nand K, Vicioso, Yorleny, Woo, Janghee, Beck, Rose, de Lima, Marcos, Caimi, Paolo, Feinberg, Daniel, Parameswaran, Reshmi

    Published in Oncoimmunology (01-01-2021)
    “…Mantle cell lymphoma (MCL) is an aggressive form of B cell non-Hodgkin's lymphoma and remains incurable under current treatment modalities. One of the main…”
    Get full text
    Journal Article